Thursday, July 7, 2022
SCIENMAG: Latest Science and Health News
No Result
View All Result
  • Login
  • HOME PAGE
  • BIOLOGY
  • CHEMISTRY AND PHYSICS
  • MEDICINE
    • Cancer
    • Infectious Emerging Diseases
  • SPACE
  • TECHNOLOGY
  • CONTACT US
  • HOME PAGE
  • BIOLOGY
  • CHEMISTRY AND PHYSICS
  • MEDICINE
    • Cancer
    • Infectious Emerging Diseases
  • SPACE
  • TECHNOLOGY
  • CONTACT US
No Result
View All Result
Scienmag - Latest science news from science magazine
No Result
View All Result
Home SCIENCE NEWS Technology and Engineering

New biomaterial regrows blood vessels and bone, RCSI research

April 20, 2021
in Technology and Engineering
0
Share on FacebookShare on Twitter

Scientists have developed a new biomaterial that regrows blood vessels and bone, potentially providing a single-stage approach when repairing large bone defects.

The study, led by researchers from RCSI University of Medicine and Health Sciences and SFI AMBER Centre, is published in the Journal of Controlled Release.

Previous RCSI-led research had found that activating a mechanosensitive gene, called placental growth factor (PGF), at different doses promoted bone regeneration and grew new blood vessels. Using this knowledge, the researchers developed a biomaterial that delivers PGF at different concentrations.

Inspired by the natural way in which bone defects regenerate, the biomaterial first releases a high dose of PGF, promoting blood vessel growth, and follows it with a more sustained lower dose, which promotes bone regeneration. When tested in a pre-clinical model, the biomaterial successfully repaired large bone defects while also regrowing blood vessels.

Current biomaterials that promote both blood vessel and bone growth typically require using more than one therapeutic drug, which means designing a more complex system that faces more challenges. Furthermore, drugs that have been approved for use in the clinic have been controversially associated with dangerous side-effects, highlighting the need for new strategies.

“More testing is needed before we can begin clinical trials, but if proven successful, this biomaterial could benefit patients when repairing bone defects by providing an alternative to current systems,” said Professor Fergal O’Brien, the study’s principal investigator and RCSI’s Director of Research and Innovation.

“In addition to repairing bone defects, our approach to regenerative medicine executed in the study provides a new framework for evaluating regenerative biomaterials for other tissue engineering applications. We are now applying this concept of ‘mechanobiology informed regenerative medicine’ to identify new therapeutics in other areas, including cartilage and spinal cord repair.”

The biomaterial was developed by researchers from the Tissue Engineering Research Group (TERG) based at RCSI and the SFI AMBER Centre. Their work was supported by the Irish Research Council, the EU BlueHuman Interreg Atlantic Area Project, the European Community’s Horizon 2020 research and innovation programme under European Research Council Advanced Grant agreement n° 788753 (ReCaP) and the Health Research Board of Ireland under the Health Research Awards – Patient-Oriented Research Scheme.

“By using a mechanobiology-informed approach, we were able to identify a promising new therapeutic candidate for bone repair and also determine the optimal concentrations required to promote both angiogenesis and osteogenesis within a single biomaterial,” said Dr Eamon Sheehy, the study’s first author and researcher in TERG.

“The regeneration of large bone defects remains a significant clinical challenge, but hopefully our new biomaterial will continue to prove beneficial in further trials.”

###

About RCSI University of Medicine and Health Sciences

Ranked number one globally for Good Health and Well-being in the Times Higher Education (THE) University Impact Rankings 2020, RCSI University of Medicine and Health Sciences is an international not-for-profit university, with its headquarters in Dublin.

RCSI is exclusively focused on education and research to drive improvements in human health worldwide. It is among the top 250 universities worldwide in the THE World University Rankings (2020) and its research is ranked first in Ireland for citations. RCSI has been awarded Athena Swan Bronze accreditation for positive gender practice in higher education.

Visit the RCSI MyHealth Expert Directory to find the details of our experts across a range of healthcare issues and concerns. Recognising their responsibility to share their knowledge and discoveries to empower people with information that leads them to better health, these clinicians and researchers are willing to engage with the media in their area of expertise.

Media Contact
Michael Sullivan
[email protected]
http://dx.doi.org/10.1016/j.jconrel.2021.03.031

Tags: Biomechanics/BiophysicsBiomedical/Environmental/Chemical EngineeringBiotechnologyMedicine/HealthOrthopedic MedicineRehabilitation/Prosthetics/Plastic SurgerySurgeryTrauma/Injury
Share25Tweet16Share4ShareSendShare
  • PAN protein domain

    Scientists discover cancer trigger that could spur targeted drug therapies

    79 shares
    Share 32 Tweet 20
  • COVID-19 fattens up our body’s cells to fuel its viral takeover

    103 shares
    Share 41 Tweet 26
  • Messenger RNA technology shows promise for developing infectious disease therapeutics

    66 shares
    Share 26 Tweet 17
  • Killing resistant prostate cancer with iron

    66 shares
    Share 26 Tweet 17
  • ‘Supergene’ wreaks havoc in a genome

    65 shares
    Share 26 Tweet 16
  • How bilingual brains work: Cross-language interplay and an integrated lexicon

    65 shares
    Share 26 Tweet 16
ADVERTISEMENT

About us

We bring you the latest science news from best research centers and universities around the world. Check our website.

Latest NEWS

COVID-19 fattens up our body’s cells to fuel its viral takeover

Scientists discover cancer trigger that could spur targeted drug therapies

Immune molecules from a llama could provide protection against a vast array of SARS-like viruses including COVID-19, researchers say

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 190 other subscribers

© 2022 Scienmag- Science Magazine: Latest Science News.

No Result
View All Result
  • HOME PAGE
  • BIOLOGY
  • CHEMISTRY AND PHYSICS
  • MEDICINE
    • Cancer
    • Infectious Emerging Diseases
  • SPACE
  • TECHNOLOGY
  • CONTACT US

© 2022 Scienmag- Science Magazine: Latest Science News.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
Posting....